Intra-Articular Dexmedetomidine: A Treatment for Chronic Knee Pain
Recruiting
N/A
Interventional Study
Chronic Knee Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 70 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chronic knee osteoarthritis (KOA) is a painful condition with limited treatment options. Non-pharmacological approaches often fall short, leading to decreased quality of life. Ozone therapy, a simple and affordable treatment, has shown promise for pain relief. Dexmedetomidine (DEX), a sedative and analgesic, has been used successfully as an adjuvant to anesthesia and local anesthetics. Given its p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients were not assigned for surgical intervention;
* Patients were free of exclusion criteria
Exclusion Criteria:
* Patients were assigned for surgical intervention;
* Patients who had uncontrolled hypertension and/or diabetes mellitus;
* Patients who had uncompensated ca…
Contacts
No contact information available.